Propanc Biopharma, Inc.: Propanc Biopharma's Joint Researcher Receives Award at Doctoral Conference at the University of Jaén

A Scientific Poster Describing a Novel Therapeutic Strategy Decreasing the Influence of the Tumor Microenvironment Propanc Biopharma, Inc. (OTC Pink: PPCB) ("Propanc" or the "Company"), a biopharmaceutical

Related Keywords

Spain ,Kostenloser Wertpapierhandel ,Toledo Cutillas ,James Nathanielsz ,Julian Kenyon ,Exchange Commission ,University Of Ja ,Young Researchers Of The University Ja ,Propanc Biopharma Inc ,Company Joint Researcher ,Company Mechanism Of Action ,Scientific Poster Describing ,Novel Therapeutic Strategy Decreasing ,Joint Researcher ,Professor Macarena Per ,Young Researchers ,Tumor Support ,Cancer Associated Fibroblasts ,Tumor Microenvironment ,Associated Fibroblasts ,Chief Scientific Officer ,Professor Per ,Propanc Biopharma ,Propanc ,Iopharma ,Joint ,Researcher ,Eceives ,Award ,Doctoral ,Conference ,University ,A 233 N ,